JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv
Dosing - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Target-Specific Oral Anticoagulants
NOAC Dose-Adjustment Recommendations in Renal Impairment and AF | Download Table
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist | touchCARDIO
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Life on a Blood Thinner: Insights and Advice from an Anticoagulant Specialist - YouTube
Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke
Safety Profile - VTE Prophylaxis | XARELTO® (rivaroxaban) HCP
NOAC Dose-Adjustment Recommendations in Renal Impairment and AF | Download Table
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist | touchCARDIO
Xarelto® - Dosing Guide
Dose Regimens in Approved Rivaroxaban Indications. 1 | Download Table
Xarelto® – Dosing – Stroke Prevention in Atrial Fibrillation
Xarelto® - Dosing Guide
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
Direct Oral Anticoagulants for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
Rivaroxaban: A New Oral Anticoagulant
